(Reuters) - The Food and Drug Administration has asked Regeneron Pharmaceuticals Inc and Sanofi SA to assess potential neurocognitive side effects of their experimental cholesterol drug, Sanofi said...
March 7 (Reuters) - The U.S. Food and Drug Administration has asked Regeneron Pharmaceuticals Inc and Sanofi SA to assess potential neurocognitive side effects of their experimental cholesterol drug, Sanofi said in its annual report on Friday.
between analysts' expectations and reported results. The figures are provided by Thomson Reuters I/B/E/S. Company Name Ticker Qtr Industry Curr EPS Est EPS Act Diff EPS Rev Est Rev Act Diff Rev ACHILLION PHARMACEUTICALS Q4 DRUG
Achillion Pharmaceuticals ( ACHN ) files an S-3 for $150M shelf offering. Post your comment!
By Spencer Osborne : The script numbers for Arena Pharmaceuticals ( ARNA ) Belviq for the last week in February are in. According to industry tracker IMS, the prescriptions for Belviq came in
patients alike would flock to the only two FDA approved weight control therapies offered by VIVUS ( VVUS ) and Arena Pharmaceuticals ( ARNA ) to aide in weight loss over and above diet and exercise. After all, obesity has assumed the dimensions
Peregrine Pharmaceuticals ( PPHM ) Q3 2014 Earnings Call March 07, 2014 11:00 am ET ..... Good day, ladies and gentlemen, and welcome to the Peregrine Pharmaceuticals , Inc. Third Quarter Fiscal Year 2014 Financial Results Complete
Market buzz remains high about several pharmaceutical companies ' interest in the orphan drug maker. InterMune ( ITMN ) considered selling itself three years ago but no deals were reached due
NEW YORK, March 7 (Reuters) - InterMune Inc, a drugmaker that specializes in treating fatal scarring of the lungs, is attracting takeover interest from several pharmaceutical companies , according to people familiar with the matter.
Complete Story »